Prognostic factors of recurrence and disease-free survival in radically resected pulmonary carcinoids: a real-world analysis

被引:1
|
作者
Spils, Marc [1 ,2 ]
Klikovits, Thomas [1 ,2 ]
Krenbek, Dagmar [3 ]
Hochmair, Maximilian Johannes [4 ]
Jankovic, Igor [1 ,2 ]
Schulte, Lisa [1 ,2 ]
Krajc, Tibor [1 ,2 ]
Benej, Michal [1 ,2 ]
Getman, Vladyslav [1 ,2 ]
Navarrete, Jose Ruiz [1 ,2 ]
Akan, Ahmet [1 ,2 ]
Mueller, Michael R. [1 ,2 ]
Aigner, Clemens [5 ]
Watzka, Stefan B. [1 ,2 ]
机构
[1] Clin Floridsdorf, Dept Thorac Surg, 68 Bruenner Str, A-1210 Vienna, Austria
[2] Clin Floridsdorf, Karl Landsteiner Inst, 68 Bruenner Str, A-1210 Vienna, Austria
[3] Clin Floridsdorf, Inst Pathol, Vienna, Austria
[4] Clin Floridsdorf, Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Vienna, Austria
[5] Vienna Gen Hosp, Dept Thorac Surg, Vienna, Austria
关键词
Lung cancer; pulmonary carcinoid (PC); recurrence; disease-free-survival (DFS); prognosis; SOCIETY EXPERT CONSENSUS; NEUROENDOCRINE TUMORS; SURGICAL-MANAGEMENT; LUNG-CANCER; PREDICTORS; DIAGNOSIS; SUBLOBAR;
D O I
10.21037/jtd-23-1681
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pulmonary carcinoids (PCs) are rare neuroendocrine lung tumors which may recur, thus worsening their otherwise favorable overall prognosis. Aiming to identify patients at risk for recurrence, we examined parameters affecting disease-free survival (DFS). Methods: A retrospective single-center analysis of 82 consecutive patients undergoing curative intent resection for primary PC tumors between 2010 and 2019 was carried out. Kaplan-Meier method was utilized for survival analysis. Independent prognostic factors were determined using multivariable Cox and logistic regression. Results: During the observation period 82 patients, 48 females (58.5%) and 34 males (41.5%) were operated, representing 84 cases of PCs, 56 typical (TCs) (66.7%) and 28 atypical (ACs) (33.3%) carcinoids. Five-year overall survival was 87.5% and 84.7%, 5-year DFS 97.5% and 74.9% (P=0.012) for TCs and ACs, respectively. Recurrences occurred in one patient (1.8%) with TCs and five patients (17.9%) with ACs (P=0.014). Using multivariable Cox regression, tumor size (cm) remained as an independent prognostic factor for reduced DFS (P=0.018). In logistic regression, nodal involvement (P=0.043) and tumor size (cm) (P=0.023) were independently associated with higher risk of recurrence. Age, sex, smoking, location, and Ki-67 index were not independently associated with recurrence or DFS. Conclusions: Recurrence in PCs after complete resection is relatively rare. However, DFS is reduced in ACs compared to TCs. Tumor size (cm) and nodal involvement appear as the most important prognostic factors associated with recurrence in PCs, independent of histologic type.
引用
收藏
页码:1911 / 1922
页数:12
相关论文
共 50 条
  • [31] A Real World Study on Adjuvant Nivolumab: Recurrence Free Survival and Toxicity in Resected Stage III and IV Melanoma
    Huang, Wendy E.
    Archer, Christine
    Yip, Desmond
    Kanjanapan, Yada
    Peters, Geoffrey
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 173 - 174
  • [32] Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience
    Liu, Lei
    Zhang, Jiaqi
    Zhao, Ke
    Guo, Chao
    Huang, Cheng
    Li, Shanqing
    Chen, Yeye
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [33] Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
    Yang Wang
    Bin Lian
    Lu Si
    ZhiHong Chi
    XiNan Sheng
    Xuan Wang
    LiLi Mao
    BiXia Tang
    SiMing Li
    XieQiao Yan
    Xue Bai
    Li Zhou
    ChuanLiang Cui
    Jun Guo
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2731 - 2740
  • [34] Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
    Wang, Yang
    Lian, Bin
    Si, Lu
    Chi, ZhiHong
    Sheng, XiNan
    Wang, Xuan
    Mao, LiLi
    Tang, BiXia
    Li, SiMing
    Yan, XieQiao
    Bai, Xue
    Zhou, Li
    Cui, ChuanLiang
    Guo, Jun
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2731 - 2740
  • [35] Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
    Luo, Pan-Quan
    Ye, Zheng-Hui
    Zhang, Li-Xiang
    Song, En-Dong
    Wei, Zhi-Jian
    Xu, A-Man
    Lu, Zhen
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (36) : 13250 - 13263
  • [36] PROGNOSTIC FACTORS FOR SURVIVAL AND DISEASE-FREE SURVIVAL IN HEPATIC METASTASES FROM COLORECTAL-CANCER TREATED BY RESECTION
    DOCI, R
    BIGNAMI, P
    MONTALTO, F
    GENNARI, L
    [J]. TUMORI JOURNAL, 1995, 81 (03): : 143 - 146
  • [37] Time-Varying Effects of Prognostic Factors Associated With Disease-Free Survival in Breast Cancer
    Natarajan, Loki
    Pu, Minya
    Parker, Barbara A.
    Thomson, Cynthia A.
    Caan, Bette J.
    Flatt, Shirley W.
    Madlensky, Lisa
    Hajek, Richard A.
    Al-Delaimy, Wael K.
    Saquib, Nazmus
    Gold, Ellen B.
    Pierce, John P.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (12) : 1463 - 1470
  • [38] Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
    Pan-Quan Luo
    Zheng-Hui Ye
    Li-Xiang Zhang
    En-Dong Song
    Zhi-Jian Wei
    A-Man Xu
    Zhen Lu
    [J]. World Journal of Clinical Cases, 2022, (36) : 13250 - 13263
  • [39] Prognostic Factors for Cancer-Specific Survival and Disease-Free Interval of Dogs with Mammary Carcinomas
    Soares, Elaine da Silva
    Valente, Fabricio Luciani
    Rocha, Carolina Camargos
    Real Pereira, Carlos Eduardo
    Sarandy, Thais Barroso
    de Oliveira, Fabiano Luiz Dulce
    de Morais Calado, Sabrina Loise
    Borges, Andrea Pacheco Batista
    [J]. VETERINARY MEDICINE INTERNATIONAL, 2023, 2023
  • [40] Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression
    Yazdani, Akram
    Haghighat, Shahpar
    [J]. BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2022, 16